We’ve been advising on and closing cannabis transactions since 2013.

Our deep knowledge of biological supply chains, successful transactions and rapidly changing cannabis sector gives our clients confidence that we understand the full lifecycle and operational risks and opportunities they face. In the not too distant future, we believe the cannabis and life science sectors will continue to move towards each other and share more in common than they do now. We will continue to be on the forefront of providing valuable insights before, during and after this evolution.

David speaking at 2018 IC3 Conference in New York City.

The GEP Difference

Established Pioneer
One of the first investment bankers in cannabis

Operational Knowledge
In both life science and cannabis companies

Bioprocessing Expertise
Inventor on two bioprocessing patents

Transactional Fluency
Over 50 transactions of various structures

Innovative Perspective
Successful tenures in Silicon Valley start-ups

Synergized Solutions
We combine our unique backgrounds to provide valuable solutions

Our team’s experience in business development and operations means that we can effectively and successfully lead incremental transactions such as joint ventures, co-development and cross-licensing, in addition to terminal transactions such as mergers, acquisitions and option-based arrangements. Learn more about our team here.

Cannabis

We began working with cannabis companies in the early days of legalization, beginning in Colorado in 2013. Our knowledge spans the full lifecycle of marijuana and hemp operators including ancillary providers:
  • Fully integrated multi-state operators, both marijuana and hemp
  • Brands
  • Grows
  • Dispensaries
  • Technology companies
  • Platform plays
  • Fully integrated multi-state operators in medical and recreational
  • Testing companies
  • Lighting providers
  • Financial services
  • Software
  • Compliance

We’ve worked with companies around the world, including in Canada, Israel and Mexico.

“Dave and his team have assisted us on a number of projects and transactions. They have consistently provided objective, intelligent and timely perspectives to our team to allow us to make the smartest decisions.”

Kyle Speidell – The Green Solution

Life Sciences

Our experience in life sciences dates back to 1989, when biotech was booming in the U.S. We’ve worked at or with notable companies such as Synergen, Somatogen, Affymetrix and Atugen. We have worked across many sub-sectors, including:

  • Pharmaceuticals
  • Genomics & gene therapy
  • Drug discovery & delivery
  • Personalized medicine
  • Implants and prosthetics
  • Diagnostics
  • Biomarkers
  • Platform technology
  • Plant-based manufacturing
  • Food safety
  • Animal health

“David and his team at Golden Eagle have done an incredible job bringing the financing and reverse merger to the fore.”

Vince Pavelock, CEO – BodySync